UBS Group AG - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 46 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$25
-76.6%
63
-71.7%
0.00%
Q4 2022$1072230.0%0.00%
Q3 2022$0
-100.0%
223
-93.8%
0.00%
Q2 2022$11,000
+83.3%
3,580
+197.3%
0.00%
Q1 2022$6,000
-88.5%
1,204
-76.8%
0.00%
Q4 2021$52,000
+147.6%
5,190
+226.2%
0.00%
Q3 2021$21,000
+110.0%
1,591
+127.9%
0.00%
Q2 2021$10,0006980.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders